[ad_1]
According to a program, the vaccination process against COVID-19 in the country is evolving according to experts.
In particular, EODY’s mobile health teams started on Monday vaccinations against COVID-19 in the Elderly Units based on planning of the Ministry of Health.
In addition, the president of the National Vaccination Committee, Maria Theodoridou He stressed that with greater availability, Greece will respond well to the great threat of the coronavirus.
According to her, the acceptance of the vaccine has overcome the initial reluctance, adding that the largest mass vaccination operation for adults is underway and 12.5 million doses of vaccine have already been distributed in more than 30 countries.
Try to vaccinate 220,000 before the end of the month
According to the information provided by the Secretary General of Primary Health Care, Marios Themistocles“Based on our population and the vaccines that have been given, we have achieved vaccination coverage that places us in the middle of the EU countries.”
He pointed out that “by January 20, we expect 120,000 people to have been vaccinated,” that is, doctors from private structures, while by the end of the month estimated that 220,000 people would have been vaccinated, given that vaccinations will have started for people over 85 years of age.
“If we add the deliveries of other orders, such as Moderna, which we expect from time to time, the number that will be vaccinated by the general population will increase,” he stressed.
The vaccination appointment platform will open on January 11.
Advantages of the AstraZeneca vaccine
At the same time, Ms Theodoridou elaborated extensively on the AstraZeneca vaccine, which has already received approval from UK regulators and is expected to receive approval from Coreper.
“It is a vaccine with a different technology,” he said.
“This vaccine, according to the evaluation, is 70% effective and is administered in two doses, with an interval that was originally set at 4 weeks and in recent days it is heard that scientists are thinking about administering the second dose until later 12 weeks. These modifications reveal an attempt to take advantage of the advantages of each study as much as possible. That is, perhaps the longer the interval between the first and second doses, the more likely it is to increase effectiveness which appears to be at a disadvantage compared to the other vaccines. “Without being fully documented, it appears that this vaccine can also prevent transmission of the virus from a vaccinated person, when they are re-infected with the new coronavirus.”
As the professor said, “It is a vaccine that we were waiting with anxiety and impatience, because it has many advantages. “It is stable at normal storage temperatures, it is cheap and can be produced in large quantities to cover large populations with vaccines.”
Commenting on what has been heard about a possible combination of this vaccine with a vaccine from another company, Ms Theodoridou stressed that “the correct thing to do is to follow what is proposed by the producer.” He also commented on the British scientists’ ideas to give a vaccine to different companies in the first and second doses, saying that “the basic rule in medicine is to continue with any vaccine that is started.”
Certainly, a vaccine alone cannot vaccinate approximately 7.8 billion people worldwide. What is needed is global cooperation, encompassing not just rich countries, but everyone, Ms Theodoridou concluded.
The cases
Earlier, EODY announced that they recorded 427 new cases of coronavirus in the country in the last 24 hours.
During the same period, 54 dead, with the death toll from the pandemic reaching 5,011.
Beside, 407 are patients treated by intubation in the ICU.
Recommendation for March type lock
It is recalled, in fact, that Manolis Dermitzakis, Professor of Genetics at the Faculty of Medicine of the University of Geneva, expressed the assessment that if we can apply a hard lock lasting 2-3 weeks The cases will be reduced considerably and, in combination with the good weather conditions in Greece, something stricter might not have been necessary afterwards.
As you said, speaking to SKAI, the people in November quarantine made the most of the possibility of movement, while in March they did not do so out of fear.
Modern Vaccine: EMA did not make a decision
Finally, it should be noted that the Committee of the European Medicines Agency (EMA) couldn’t make a decision on monday on the Modern vaccine and will resume its meeting on Wednesday, January 6.
The EMA will make no further announcements today, the agency said on Twitter.
